Suppr超能文献

前列腺体积随时间的变化:巴尔的摩纵向衰老研究的结果

Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging.

作者信息

Loeb Stacy, Kettermann Anna, Carter H Ballentine, Ferrucci Luigi, Metter E Jeffrey, Walsh Patrick C

机构信息

James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.

出版信息

J Urol. 2009 Oct;182(4):1458-62. doi: 10.1016/j.juro.2009.06.047. Epub 2009 Aug 15.

Abstract

PURPOSE

According to a 1944 publication by Swyer benign prostatic hyperplasia develops in some men after age 45 with further prostatic growth whereas in other men prostate size remains stable or decreases with advancing age. Although there is an abundance of literature describing prostatic enlargement in association with benign prostatic hyperplasia, less is known about the phenomenon of prostate atrophy.

MATERIALS AND METHODS

In the Baltimore Longitudinal Study of Aging serial pelvic magnetic resonance imaging was performed in men without prostate cancer beginning in 1993. From this population we retrospectively identified 278 men with 2 or more magnetic resonance imaging determined prostate volume measurements to examine differential growth rates in a cohort of community men over time.

RESULTS

Median age was 58 years and median prostate size was 28 cc at study entry. At a median followup of 4.3 years prostate size increased in 61.9% and remained stable or decreased in 38.1% of men. The median rate of volume change was 0.6 cc per year (range -9.9 to 62.1), corresponding to a median growth rate of 2.5% per year (range -29.2 to 176.4%). During followup 64.6% of men with an initial prostate size less than 40 cc had prostate growth compared to only 50.9% of men with an initial prostate size of 40 cc or greater.

CONCLUSIONS

These results suggest that changes in prostate size are highly variable among aging men. Although benign prostatic hyperplasia is common, a considerable proportion of aging men have a stable or decreasing prostate size. Further research is needed to identify the underlying mechanism for such differences in prostate growth.

摘要

目的

根据斯怀尔1944年发表的一篇文章,良性前列腺增生在45岁以后会在一些男性中发生,前列腺会进一步生长,而在其他男性中,前列腺大小会随着年龄增长保持稳定或缩小。尽管有大量文献描述了与良性前列腺增生相关的前列腺肿大,但关于前列腺萎缩现象的了解较少。

材料与方法

在巴尔的摩纵向衰老研究中,从1993年开始对无前列腺癌的男性进行系列盆腔磁共振成像检查。从该人群中,我们回顾性地确定了278名男性,他们有2次或更多次通过磁共振成像测定的前列腺体积测量值,以研究一组社区男性随时间的差异生长率。

结果

研究开始时,中位年龄为58岁,中位前列腺大小为28立方厘米。在中位随访4.3年时,61.9%的男性前列腺大小增加,38.1%的男性前列腺大小保持稳定或缩小。体积变化的中位速率为每年0.6立方厘米(范围为-9.9至62.1),相当于每年2.5%的中位生长率(范围为-29.2至176.4%)。在随访期间,初始前列腺大小小于40立方厘米的男性中有64.6%出现前列腺生长,而初始前列腺大小为40立方厘米或更大的男性中只有50.9%出现前列腺生长。

结论

这些结果表明,老年男性前列腺大小的变化差异很大。尽管良性前列腺增生很常见,但相当一部分老年男性的前列腺大小稳定或缩小。需要进一步研究以确定前列腺生长这种差异的潜在机制。

相似文献

1
Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging.
J Urol. 2009 Oct;182(4):1458-62. doi: 10.1016/j.juro.2009.06.047. Epub 2009 Aug 15.
2
Does prostate growth confound prostate specific antigen velocity? Data from the Baltimore longitudinal study of aging.
J Urol. 2008 Oct;180(4):1314-7; discussion 1317. doi: 10.1016/j.juro.2008.06.033. Epub 2008 Aug 15.
3
Prostate volume growth rate changes over time: Results from men 18 to 92 years old in a longitudinal community-based study.
J Huazhong Univ Sci Technolog Med Sci. 2016 Dec;36(6):796-800. doi: 10.1007/s11596-016-1664-x. Epub 2016 Dec 7.
5
Metabolic factors associated with benign prostatic hyperplasia.
J Clin Endocrinol Metab. 2006 Jul;91(7):2562-8. doi: 10.1210/jc.2005-2799. Epub 2006 Apr 11.

引用本文的文献

3
Mapping of prostate cancer microvascular patterns using super-resolution ultrasound imaging.
Eur Radiol Exp. 2025 Feb 20;9(1):25. doi: 10.1186/s41747-025-00561-6.
5
7
Effect of TNF-α Inhibitor Therapy on Growth of the Prostate Gland.
Eur Urol Focus. 2024 Jul;10(4):641-647. doi: 10.1016/j.euf.2023.10.015. Epub 2023 Oct 27.

本文引用的文献

1
Urologic diseases in america project: benign prostatic hyperplasia.
J Urol. 2008 May;179(5 Suppl):S75-80. doi: 10.1016/j.juro.2008.03.141.
4
Post-natal growth changes in the human prostate.
J Anat. 1944 Jul;78(Pt 4):130-45.
5
Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort.
J Urol. 2006 Mar;175(3 Pt 1):1018-22; discussion 1022. doi: 10.1016/S0022-5347(05)00408-8.
7
Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2257-60. doi: 10.1158/1055-9965.EPI-04-0715.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验